Recent developments in investment trends highlight opportunities in higher-risk sectors, including clinical-stage biotech, micro-cap stocks, and junior gold mining companies, facilitated by specific exchange-traded funds (ETFs) that help mitigate risk. The Virtus LifeSci Biotech Clinical Trials ETF (BBC) offers targeted exposure to 135 biotech companies, showing a notable YTD increase of about 38%. The iShares Micro-Cap ETF (IWC) targets a broad index of volatile small firms, with a 24% YTD gain, while the VanEck Junior Gold Miners ETF (GDXJ) focuses on early-stage gold mining companies, reporting a 13% YTD return. These funds allow investors to access potentially lucrative but speculative market segments despite inherent risks and high fees.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.marketbeat.com/articles/venture-into-high-volatility-corners-of-the-market-with-these-3-etfs/
